BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Roth GA, Zimmermann M, Lubsczyk BA, Pilz J, Faybik P, Hetz H, Hacker S, Mangold A, Bacher A, Krenn CG. Up-regulation of interleukin 33 and soluble ST2 serum levels in liver failure. J Surg Res. 2010;163:e79-e83. [PMID: 20638676 DOI: 10.1016/j.jss.2010.04.004] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Dieplinger B, Egger M, Koehler W, Firlinger F, Poelz W, Lenz K, Haltmayer M, Mueller T. Prognostic value of soluble ST2 in an unselected cohort of patients admitted to an intensive care unit — The Linz Intensive Care Unit (LICU) study. Clinica Chimica Acta 2012;413:587-93. [DOI: 10.1016/j.cca.2011.11.028] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
2 Barbier L, Robin A, Sindayigaya R, Ducousso H, Dujardin F, Thierry A, Hauet T, Girard JP, Pellerin L, Gombert JM, Herbelin A, Salamé E. Endogenous Interleukin-33 Acts as an Alarmin in Liver Ischemia-Reperfusion and Is Associated With Injury After Human Liver Transplantation. Front Immunol 2021;12:744927. [PMID: 34621275 DOI: 10.3389/fimmu.2021.744927] [Reference Citation Analysis]
3 Wei H, Zhang J, Li H, Ren H, Hao X, Huang Y. GP73, a new marker for diagnosing HBV-ACLF in population with chronic HBV infections. Diagn Microbiol Infect Dis. 2014;79:19-24. [PMID: 24560809 DOI: 10.1016/j.diagmicrobio.2014.01.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
4 Seidelin JB, Rogler G, Nielsen OH. A role for interleukin-33 in T(H)2-polarized intestinal inflammation? Mucosal Immunol 2011;4:496-502. [PMID: 21613987 DOI: 10.1038/mi.2011.22] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
5 Zharichenko N, Njoku DB. The Role of Pro-Inflammatory and Regulatory Signaling by IL-33 in the Brain and Liver: A Focused Systematic Review of Mouse and Human Data and Risk of Bias Assessment of the Literature. Int J Mol Sci 2020;21:E3933. [PMID: 32486265 DOI: 10.3390/ijms21113933] [Reference Citation Analysis]
6 Wang M, Shen G, Xu L, Liu X, Brown JM, Feng D, Ross RA, Gao B, Liangpunsakul S, Ju C. IL-1 receptor like 1 protects against alcoholic liver injury by limiting NF-κB activation in hepatic macrophages. Journal of Hepatology 2018;68:109-17. [DOI: 10.1016/j.jhep.2017.08.023] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
7 Steinmann S, Schoedsack M, Heinrich F, Breda PC, Ochel A, Tiegs G, Neumann K. Hepatic ILC2 activity is regulated by liver inflammation-induced cytokines and effector CD4+ T cells. Sci Rep 2020;10:1071. [PMID: 31974518 DOI: 10.1038/s41598-020-57985-w] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
8 Mehraj V, Ponte R, Routy JP. The Dynamic Role of the IL-33/ST2 Axis in Chronic Viral-infections: Alarming and Adjuvanting the Immune Response. EBioMedicine 2016;9:37-44. [PMID: 27397514 DOI: 10.1016/j.ebiom.2016.06.047] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
9 Jin Z, Lei L, Lin D, Liu Y, Song Y, Gong H, Zhu Y, Mei Y, Hu B, Wu Y, Zhang G, Liu H. IL-33 Released in the Liver Inhibits Tumor Growth via Promotion of CD4+ and CD8+ T Cell Responses in Hepatocellular Carcinoma. J Immunol 2018;201:3770-9. [PMID: 30446569 DOI: 10.4049/jimmunol.1800627] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
10 Shen Y, Li J, Wang SQ, Jiang W. Ambiguous roles of innate lymphoid cells in chronic development of liver diseases. World J Gastroenterol 2018; 24(18): 1962-1977 [PMID: 29760540 DOI: 10.3748/wjg.v24.i18.1962] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
11 Neumann K, Schiller B, Tiegs G. NLRP3 Inflammasome and IL-33: Novel Players in Sterile Liver Inflammation. Int J Mol Sci 2018;19:E2732. [PMID: 30213101 DOI: 10.3390/ijms19092732] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
12 Oztas E, Kuzu UB, Zengin NI, Kalkan IH, Onder FO, Yildiz H, Celik HT, Akdogan M, Kilic MY, Koksal AS. Can Serum ST2 Levels Be Used as a Marker of Fibrosis in Chronic Hepatitis B Infection? Medicine (Baltimore). 2015;94:e1889. [PMID: 26632683 DOI: 10.1097/md.0000000000001889] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
13 Dieplinger B, Mueller T. Soluble ST2 in heart failure. Clin Chim Acta 2015;443:57-70. [PMID: 25269091 DOI: 10.1016/j.cca.2014.09.021] [Cited by in Crossref: 76] [Cited by in F6Publishing: 68] [Article Influence: 9.5] [Reference Citation Analysis]
14 Arshad MI, Piquet-pellorce C, L'helgoualc'h A, Rauch M, Patrat-delon S, Ezan F, Lucas-clerc C, Nabti S, Lehuen A, Cubero FJ, Girard J, Trautwein C, Samson M. TRAIL but not FasL and TNFα, regulates IL-33 expression in murine hepatocytes during acute hepatitis. Hepatology 2012;56:2353-62. [DOI: 10.1002/hep.25893] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 5.1] [Reference Citation Analysis]
15 Yang Q, Shi Y, Yang Y, Lou G, Chen Z. The sterile inflammation in the exacerbation of HBV-associated liver injury. Mediators Inflamm. 2015;2015:508681. [PMID: 25892853 DOI: 10.1155/2015/508681] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
16 Barbier L, Ferhat M, Salamé E, Robin A, Herbelin A, Gombert JM, Silvain C, Barbarin A. Interleukin-1 Family Cytokines: Keystones in Liver Inflammatory Diseases. Front Immunol 2019;10:2014. [PMID: 31507607 DOI: 10.3389/fimmu.2019.02014] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 9.7] [Reference Citation Analysis]
17 Nah EH, Cho S, Kim S, Cho HI. Reference interval and the role of soluble suppression of tumorigenicity 2 (sST2) in subclinical cardiac dysfunction at health checkups. J Clin Lab Anal 2020;34:e23461. [PMID: 32638437 DOI: 10.1002/jcla.23461] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
18 Brenner C, Galluzzi L, Kepp O, Kroemer G. Decoding cell death signals in liver inflammation. J Hepatol. 2013;59:583-594. [PMID: 23567086 DOI: 10.1016/j.jhep.2013.03.033] [Cited by in Crossref: 446] [Cited by in F6Publishing: 424] [Article Influence: 49.6] [Reference Citation Analysis]
19 Arshad MI, Rauch M, L'helgoualc'h A, Julia V, Leite-de-Moraes MC, Lucas-Clerc C, Piquet-Pellorce C, Samson M. NKT cells are required to induce high IL-33 expression in hepatocytes during ConA-induced acute hepatitis. Eur J Immunol 2011;41:2341-8. [PMID: 21557213 DOI: 10.1002/eji.201041332] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 4.6] [Reference Citation Analysis]
20 Bessa J, Meyer CA, de Vera Mudry MC, Schlicht S, Smith SH, Iglesias A, Cote-sierra J. Altered subcellular localization of IL-33 leads to non-resolving lethal inflammation. Journal of Autoimmunity 2014;55:33-41. [DOI: 10.1016/j.jaut.2014.02.012] [Cited by in Crossref: 95] [Cited by in F6Publishing: 98] [Article Influence: 11.9] [Reference Citation Analysis]
21 Huan SL, Zhao JG, Wang ZL, Gao S, Wang K. Relevance of serum interleukin-33 and ST2 levels and the natural course of chronic hepatitis B virus infection. BMC Infect Dis 2016;16:200. [PMID: 27180842 DOI: 10.1186/s12879-016-1543-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
22 Mueller T, Dieplinger B. The Presage(®) ST2 Assay: analytical considerations and clinical applications for a high-sensitivity assay for measurement of soluble ST2. Expert Rev Mol Diagn 2013;13:13-30. [PMID: 23256700 DOI: 10.1586/erm.12.128] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 5.6] [Reference Citation Analysis]
23 Milovanovic M, Volarevic V, Radosavljevic G, Jovanovic I, Pejnovic N, Arsenijevic N, Lukic ML. IL-33/ST2 axis in inflammation and immunopathology. Immunol Res. 2012;52:89-99. [PMID: 22392053 DOI: 10.1007/s12026-012-8283-9] [Cited by in Crossref: 156] [Cited by in F6Publishing: 160] [Article Influence: 15.6] [Reference Citation Analysis]
24 Bleau C, Filliol A, Samson M, Lamontagne L. Mouse Hepatitis Virus Infection Induces a Toll-Like Receptor 2-Dependent Activation of Inflammatory Functions in Liver Sinusoidal Endothelial Cells during Acute Hepatitis. J Virol. 2016;90:9096-9113. [PMID: 27489277 DOI: 10.1128/jvi.01069-16] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
25 Yazdani HO, Chen HW, Tohme S, Tai S, van der Windt DJ, Loughran P, Rosborough BR, Sud V, Beer-Stolz D, Turnquist HR, Tsung A, Huang H. IL-33 exacerbates liver sterile inflammation by amplifying neutrophil extracellular trap formation. J Hepatol 2017:S0168-8278(17)32291-2. [PMID: 28943296 DOI: 10.1016/j.jhep.2017.09.010] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 5.8] [Reference Citation Analysis]
26 Carrière V, Arshad MI, Le Seyec J, Lefevre B, Farooq M, Jan A, Manuel C, Touami-Bernard L, Lucas-Clerc C, Genet V, Gascan H, Girard JP, Chalmel F, Lamontagne L, Piquet-Pellorce C, Samson M. Endogenous IL-33 Deficiency Exacerbates Liver Injury and Increases Hepatic Influx of Neutrophils in Acute Murine Viral Hepatitis. Mediators Inflamm 2017;2017:1359064. [PMID: 28607531 DOI: 10.1155/2017/1359064] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
27 Wang J, Cai Y, Ji H, Feng J, Ayana DA, Niu J, Jiang Y. Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis B. J Interferon Cytokine Res. 2012;32:248-253. [PMID: 22304300 DOI: 10.1089/jir.2011.0109] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 5.2] [Reference Citation Analysis]
28 Cottagiri M, Nyandjo M, Stephens M, Mantilla JJ, Saito H, Mackay IR, Rose NR, Njoku DB. In drug-induced, immune-mediated hepatitis, interleukin-33 reduces hepatitis and improves survival independently and as a consequence of FoxP3+ T-cell activity. Cell Mol Immunol 2019;16:706-17. [PMID: 30030493 DOI: 10.1038/s41423-018-0087-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
29 Wang Z, Wu L, Pan B, Chen Y, Zhang T, Tang N. Interleukin 33 mediates hepatocyte autophagy and innate immune response in the early phase of acetaminophen-induced acute liver injury. Toxicology 2021;456:152788. [PMID: 33887374 DOI: 10.1016/j.tox.2021.152788] [Reference Citation Analysis]
30 Erhardt A, Tiegs G. IL-33--a cytokine which balances on a knife’s edge? J Hepatol. 2012;56:7-10. [PMID: 21703171 DOI: 10.1016/j.jhep.2011.05.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
31 Gao S, Huan S, Han L, Li F, Ji X, Li X, Fan Y, Wang K. Overexpression of serum sST2 is associated with poor prognosis in acute-on-chronic hepatitis B liver failure. Clinics and Research in Hepatology and Gastroenterology 2015;39:315-23. [DOI: 10.1016/j.clinre.2014.10.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
32 Arshad MI, Patrat-Delon S, Piquet-Pellorce C, L'helgoualc'h A, Rauch M, Genet V, Lucas-Clerc C, Bleau C, Lamontagne L, Samson M. Pathogenic mouse hepatitis virus or poly(I:C) induce IL-33 in hepatocytes in murine models of hepatitis. PLoS One 2013;8:e74278. [PMID: 24058536 DOI: 10.1371/journal.pone.0074278] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
33 Parikh RH, Seliger SL, Christenson R, Gottdiener JS, Psaty BM, deFilippi CR. Soluble ST2 for Prediction of Heart Failure and Cardiovascular Death in an Elderly, Community-Dwelling Population. J Am Heart Assoc. 2016;5:pii: e003188. [PMID: 27481133 DOI: 10.1161/jaha.115.003188] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
34 Gonzalez-polo V, Pucci-molineris M, Cervera V, Gambaro S, Yantorno SE, Descalzi V, Tiribelli C, Gondolesi GE, Meier D. Group 2 innate lymphoid cells exhibit progressively higher levels of activation during worsening of liver fibrosis. Annals of Hepatology 2019;18:366-72. [DOI: 10.1016/j.aohep.2018.12.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
35 Mueller T, Jaffe AS. Soluble ST2—Analytical Considerations. The American Journal of Cardiology 2015;115:8B-21B. [DOI: 10.1016/j.amjcard.2015.01.035] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 7.4] [Reference Citation Analysis]
36 Chen S, Wu L, Peng L, Wang X, Tang N. Hepatitis B virus X protein (HBx) promotes ST2 expression by GATA2 in liver cells. Mol Immunol. 2020;123:32-39. [PMID: 32413787 DOI: 10.1016/j.molimm.2020.04.024] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
37 Lei Z, Mo Z, Zhu J, Pang X, Zheng X, Wu Z, Wang K, Li X, Xie D, Gao Z. Soluble ST2 plasma concentrations predict mortality in HBV-related acute-on-chronic liver failure. Mediators Inflamm 2015;2015:535938. [PMID: 25892854 DOI: 10.1155/2015/535938] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
38 Wang J, Zhao P, Guo H, Sun X, Jiang Z, Xu L, Feng J, Niu J, Jiang Y. Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis C. Mediators Inflamm. 2012;2012:819636. [PMID: 22315510 DOI: 10.1155/2012/819636] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 3.5] [Reference Citation Analysis]
39 Xu D, Li S, Lin L, Qi F, Hang X, Sun Y. Gene expression profiling to identify the toxicities and potentially relevant disease outcomes due to endosulfan exposure. Toxicol Res (Camb) 2016;5:621-32. [PMID: 30090376 DOI: 10.1039/c5tx00332f] [Cited by in Crossref: 8] [Article Influence: 1.3] [Reference Citation Analysis]
40 Arshad MI, Piquet-Pellorce C, Samson M. IL-33 and HMGB1 alarmins: sensors of cellular death and their involvement in liver pathology. Liver Int. 2012;32:1200-1210. [PMID: 22530772 DOI: 10.1111/j.1478-3231.2012.02802.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 4.3] [Reference Citation Analysis]